BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9031792)

  • 1. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.
    Wolf P; Fink-Puches R; Reimann-Weber A; Kerl H
    Dermatology; 1997; 194(1):53-4. PubMed ID: 9031792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of squamous cell carcinoma after photodynamic therapy with methyl aminoleuvulinate.
    Calista D
    Br J Dermatol; 2014 Oct; 171(4):905-8. PubMed ID: 24702060
    [No Abstract]   [Full Text] [Related]  

  • 3. Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy.
    Guarneri C; Vaccaro M
    J Am Acad Dermatol; 2009 Mar; 60(3):521-2. PubMed ID: 19231656
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
    Maydan E; Nootheti PK; Goldman MP
    J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
    Lang K; Schulte KW; Ruzicka T; Fritsch C
    Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
    Wolf P; Rieger E; Kerl H
    J Am Acad Dermatol; 1993 Jan; 28(1):17-21. PubMed ID: 8318069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia of the scalp after ineffective treatment of Bowen's disease using red light 5-aminolevulinic acid photodynamic therapy: two case reports.
    Letada PR; Uebelhoer NS; Masters R; Satter EK; Shumaker PR
    Dermatol Surg; 2010 Nov; 36(11):1786-9. PubMed ID: 20961355
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: photodynamic therapy with methyl aminolevulinate induces phototoxic reactions on areas of the nose adjacent to basal cell carcinomas and actinic keratoses.
    Toll A; Parera ME; Vélez M; Pujol RM
    Dermatol Surg; 2008 Aug; 34(8):1145-7; discussion 1147-8. PubMed ID: 18518890
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminolevulinic acid and photodynamic combination therapy in the treatment of actinic keratoses: caring for the patient.
    Harvie SE
    Dermatol Nurs; 2007 Feb; 19(1):31-4, 39. PubMed ID: 17330552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses.
    Halldin CB; Paoli J; Sandberg C; Ericson MB; Wennberg AM
    Acta Derm Venereol; 2008; 88(3):311-3. PubMed ID: 18480950
    [No Abstract]   [Full Text] [Related]  

  • 15. Late erythema after photodynamic therapy to the face.
    Misra A; Maybury K; Eltigani TA
    Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
    [No Abstract]   [Full Text] [Related]  

  • 16. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
    Kerr AC; Ferguson J; Ibbotson SH
    Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid development of squamous cell carcinoma after photodynamic therapy.
    Liang WM; Theng TS; Lim KS; Tan WP
    Dermatol Surg; 2014 May; 40(5):586-8. PubMed ID: 24858258
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral facial palsy after topical photodynamic therapy for facial actinic keratoses.
    Gemigniani F; Bodet D; González-Llavona B; García-Patos V
    J Am Acad Dermatol; 2014 Sep; 71(3):e90-2. PubMed ID: 25128142
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellulitis as a postprocedural complication of topical 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis.
    Wolfe CM; Hatfield K; Cognetta AB
    J Drugs Dermatol; 2007 May; 6(5):544-8. PubMed ID: 17679192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.